Business Context and Reporting Period
This Form 8-K reports the results of the 2026 Annual Meeting of Stockholders held by Xeris Biopharma Holdings, Inc. on June 4, 2026. The record date for the meeting was April 14, 2026, with 172,625,762 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Three proposals were submitted to stockholders, all of which were approved or ratified:
- Proposal One (Election of Directors): Two Class II director nominees were elected by a plurality vote.
- Dawn Halkuff: 62,581,577 votes For; 24,906,166 votes Withhold.
- John Johnson: 52,665,077 votes For; 34,822,666 votes Withhold.
- Proposal Two (Ratification of Auditors): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Votes: 125,789,818 For; 1,032,530 Against; 1,445,725 Abstain.
- Proposal Three (Say-on-Pay): Stockholders approved the advisory vote on named executive officer compensation.
- Votes: 82,230,204 For; 4,658,035 Against; 599,504 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Investor Verification Checklist
- Verify the final voting percentages for the election of Class II directors, noting the significant number of broker non-votes (40,780,330) which did not count toward the plurality threshold.
- Confirm the ratification of Ernst & Young LLP as the auditor for the 2026 fiscal year.
- Review the Definitive Proxy Statement on Schedule 14A (filed April 23, 2026) for detailed executive compensation data referenced in the Say-on-Pay vote.
- Note that 128,268,073 shares were present or represented by proxy, constituting a quorum.